Promoted Content Promoted Content


Find Clinical Drug Development Pipelines & Deals | PipelineProspector


All Data

Filters Filter refresh
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Bitopertin

            Therapeutic Area: Rare Diseases and Disorders Product Name: RO4917838

            Highest Development Status: Preclinical Product Type: Small molecule

            Partner/Sponsor/Collaborator: Disc medicine

            Deal Size: $200.0 million Upfront Cash: Undisclosed

            Deal Type: Collaboration May 27, 2021


            Under the terms of the agreement, Disc Medicine will obtain exclusive, global rights to and be responsible for all development, manufacturing, and commercialization of bitopertin and related back up compounds.